Next Article in Journal
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Next Article in Special Issue
CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
Previous Article in Journal
Mathematical Modeling and Analysis of the Dynamics of RNA Viruses in Presence of Immunity and Treatment: A Case Study of SARS-CoV-2
Previous Article in Special Issue
Overcoming Aging-Associated Poor Influenza Vaccine Responses with CpG 1018 Adjuvant
 
 
Editorial

Article Versions Notes

Vaccines 2023, 11(2), 202; https://doi.org/10.3390/vaccines11020202
Action Date Notes Link
article xml file uploaded 17 January 2023 10:11 CET Original file -
article xml uploaded. 17 January 2023 10:11 CET Update https://www.mdpi.com/2076-393X/11/2/202/xml
article pdf uploaded. 17 January 2023 10:11 CET Version of Record https://www.mdpi.com/2076-393X/11/2/202/pdf
article html file updated 17 January 2023 10:12 CET Original file -
article html file updated 1 March 2023 10:02 CET Update -
article html file updated 8 March 2023 00:02 CET Update https://www.mdpi.com/2076-393X/11/2/202/html
Back to TopTop